176 related articles for article (PubMed ID: 38117953)
1. Identification of a Dual Autophagy and REV-ERB Inhibitor with
Palomba M; Vecchio D; Allavena G; Capaccio V; De Mei C; Scarpelli R; Grimaldi B
J Med Chem; 2024 Jan; 67(1):349-379. PubMed ID: 38117953
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy.
Maycotte P; Aryal S; Cummings CT; Thorburn J; Morgan MJ; Thorburn A
Autophagy; 2012 Feb; 8(2):200-12. PubMed ID: 22252008
[TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells.
De Mei C; Ercolani L; Parodi C; Veronesi M; Lo Vecchio C; Bottegoni G; Torrente E; Scarpelli R; Marotta R; Ruffili R; Mattioli M; Reggiani A; Wade M; Grimaldi B
Oncogene; 2015 May; 34(20):2597-608. PubMed ID: 25023698
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
[TBL] [Abstract][Full Text] [Related]
5. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J
Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508
[No Abstract] [Full Text] [Related]
6. Synthesis and in Vitro Anticancer Activity of the First Class of Dual Inhibitors of REV-ERBβ and Autophagy.
Torrente E; Parodi C; Ercolani L; De Mei C; Ferrari A; Scarpelli R; Grimaldi B
J Med Chem; 2015 Aug; 58(15):5900-15. PubMed ID: 26135471
[TBL] [Abstract][Full Text] [Related]
7. Circadian clock: Time for novel anticancer strategies?
Ercolani L; Ferrari A; De Mei C; Parodi C; Wade M; Grimaldi B
Pharmacol Res; 2015 Oct; 100():288-95. PubMed ID: 26319800
[TBL] [Abstract][Full Text] [Related]
8. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.
McAfee Q; Zhang Z; Samanta A; Levi SM; Ma XH; Piao S; Lynch JP; Uehara T; Sepulveda AR; Davis LE; Winkler JD; Amaravadi RK
Proc Natl Acad Sci U S A; 2012 May; 109(21):8253-8. PubMed ID: 22566612
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
10. Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy.
Fong W; To KKW
Recent Pat Anticancer Drug Discov; 2021; 16(2):204-221. PubMed ID: 33413069
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms.
Ferreira PMP; Sousa RWR; Ferreira JRO; Militão GCG; Bezerra DP
Pharmacol Res; 2021 Jun; 168():105582. PubMed ID: 33775862
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
[TBL] [Abstract][Full Text] [Related]
13. Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review.
Mohsen S; Sobash PT; Algwaiz GF; Nasef N; Al-Zeidaneen SA; Karim NA
Curr Oncol; 2022 Mar; 29(3):1695-1708. PubMed ID: 35323341
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer.
Yi H; Ye T; Ge M; Yang M; Zhang L; Jin S; Ye X; Long B; Li L
Oncol Rep; 2018 Feb; 39(2):711-720. PubMed ID: 29207150
[TBL] [Abstract][Full Text] [Related]
15. Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
Santiago-O'Farrill JM; Weroha SJ; Hou X; Oberg AL; Heinzen EP; Maurer MJ; Pang L; Rask P; Amaravadi RK; Becker SE; Romero I; Rubio MJ; Matias-Guiu X; Santacana M; Llombart-Cussac A; Poveda A; Lu Z; Bast RC
Cancer; 2020 Feb; 126(4):894-907. PubMed ID: 31714594
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors.
Bagamanshina AV; Troitskaya OS; Nushtaeva AA; Yunusova AY; Starykovych MO; Kuligina EV; Kit YY; Richter M; Wohlfromm F; Kähne T; Lavrik IN; Richter VA; Koval OA
Biomed Res Int; 2019; 2019():4087160. PubMed ID: 31317028
[TBL] [Abstract][Full Text] [Related]
17. Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.
Carew JS; Medina EC; Esquivel JA; Mahalingam D; Swords R; Kelly K; Zhang H; Huang P; Mita AC; Mita MM; Giles FJ; Nawrocki ST
J Cell Mol Med; 2010 Oct; 14(10):2448-59. PubMed ID: 19583815
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
Kapuy O; Korcsmáros T
PLoS One; 2022; 17(4):e0266337. PubMed ID: 35390060
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy.
Xu CX; Zhao L; Yue P; Fang G; Tao H; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Cancer Biol Ther; 2011 Sep; 12(6):549-55. PubMed ID: 21738008
[TBL] [Abstract][Full Text] [Related]
20. Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib.
Corallo D; Pastorino F; Pantile M; Mariotto E; Caicci F; Viola G; Ponzoni M; Tonini GP; Aveic S
J Exp Clin Cancer Res; 2020 Sep; 39(1):195. PubMed ID: 32962733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
